Improve Oral Oncolytic Workflow and Reduce Treatment Delays with a Pharmacist Collaborative Practice Agreement
Julia Kerr, PharmD
Pharmacy Program Coordinator
I graduated from the University of Wyoming School of Pharmacy in 2002. I went on to complete the Oncology Pharmacy Residency Program at St. Luke’s Cancer Institute in Boise, Idaho, the following year. Upon completion, I accepted an oncology pharmacy position at St. Luke’s where I worked for many years in the outpatient infusion pharmacy. For the past several years, I have transitioned to working exclusively with the Oral Oncology Pharmacy Program at St. Luke’s. And in recent years, I have been the Pharmacy Program Coordinator for this department. I have had the pleasure of precepting many oncology pharmacy residents over the years and have enjoyed the opportunity to work with them on valuable projects, such as the one being presented at ACCC. I am also an active member with the National Community Oncology Dispensing Association (NCODA), where I currently serve as a Regional Leader.
Clinical Oncology Pharmacist
Amanda Wright, PharmD, has been a clinical oncology pharmacist since 2019. She received a bachelor’s degree in microbiology from the University of Idaho in 2013 and her Doctor of Pharmacy degree from Washington State University in 2017. Dr. Wright completed a generalized hospital pharmacy residency at St. Luke’s Boise Medical Center, and a specialized oncology pharmacy residency at St. Luke’s Cancer Institute, formerly Mountain States Tumor Institute. She currently works in the medically integrated pharmacy at St. Luke’s Cancer Institute and on the adult oncology floor in the St. Luke’s Boise Medical Center. Dr. Wright has been involved in the creation and implementation of the oral oncolytic collaborative practice agreement over the last two years. She enjoys spending her free time with her family and two Golden Retrievers and helps on the family cattle ranch when able.
|Access Date||Quiz Result||Score||Actions|